Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...

A new study reveals that reprogramming specialized cells to become different types of cells, a key process in regenerative medicine, faces a major hurdle. The challenge lies in the DNA methylation ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year ...

A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...